Expert Interview
Discussing Roivant's Phase 3 results for once-daily oral brepocitinib for patients with Dermatomyositis
Ticker(s): ROIVInstitution: University of Pittsburgh
- Professor of Rheumatology and Director of the Myositis Center at the University of Pittsburgh
- Manages 50+ patients for dermatomyositis
- Academic interests center around investigation and treatment of inflammatory myopathy, with an emphasis on clinical interests, antibody associations, pathogenesis, and treatment
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
